LEADER 04508nam  22006855  450 
001 9910886987103321
005 20250807135922.0
010   $a3-031-65986-4
024 7 $a10.1007/978-3-031-65986-7
035   $a(CKB)34985226900041
035   $a(MiAaPQ)EBC31657827
035   $a(Au-PeEL)EBL31657827
035   $a(DE-He213)978-3-031-65986-7
035   $a(EXLCZ)9934985226900041
100   $a20240911d2024      u|         0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAntimicrobial Resistance: Factors to Findings $eOmics and Systems Biology Approaches /$fedited by Vijay Soni, Ajay Suresh Akhade
205   $a1st ed. 2024.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2024.
215   $a1 online resource (459 pages)
311 08$a3-031-65985-6 
327   $aAntimicrobial resistance and factors -- Genomics as a tool to track global AMR -- Meta-transcriptomics to reveal mechanisms of drug action and resistance -- Use of proteomics to study bacterial virulence and AMR -- Metabolomics to understand bacterial and drug metabolism -- Microbiome and AMR: A One Health perspective -- Environmental reservoirs, genomic epidemiology, and mobile genetic elements -- Multiomics approach to control AMR -- Systems biology and AMR -- Host-directed omics approaches to control AMR -- Role of AI and Machine Learning in omics analysis of AMR evolution and surveillance -- Drug discovery and AMR treatments using an omics-based approach -- Future perspectives of omics-systems biology to control AMR: Recommendations and future directions.
330   $aAntimicrobial resistance (AMR) is increasing globally at an incredible rate, and many infectious diseases have already reached an alarming stage of resistance to existing treatments. WHO reports that nearly1.27 million people currently die each year due to resistant infections, and AMR is projected to account for 10 million annual deaths globally by 2050. There is an urgent need for novel approaches to address this issue. Omics technologies are powerful research tools used extensively to study pathogen biology and the activity of microbial agents. These tools, paired with systems biology approaches, can provide novel insights into antimicrobial susceptibility and resistance, and aid in the development of new, more effective measures to combat resistant pathogens. This book provides a comprehensive overview of omics technologies to study pathogen biology, including proteomics, genomics, transcriptomics, metabolomics, and microbiome analysis, and the role of systems biology in developing strategies to combat resistant pathogens. It addresses environmental reservoirs and mobile genetic agents in AMR, host-pathogen interactions and physiology in the development of resistance, drug repurposing and development, and cutting-edge tools such as machine learning, AI for big data analysis, and genomic surveillance. The final section discusses future perspectives on omics-systems biology in AMR, and identifies opportunities for scientific collaboration in the global fight against antimicrobial resistance. This book serves as a comprehensive and accessible resource for researchers in academia and industry focused on immunology, drug development, biotechnology, and systems biology.
606   $aImmunology
606   $aImmune response
606   $aPathogenic microorganisms
606   $aBioinformatics
606   $aDiseases$xCauses and theories of causation
606   $aGenomics
606   $aImmunology
606   $aAntimicrobial Responses
606   $aComputational and Systems Biology
606   $aPathogenesis
606   $aGenomics
615  0$aImmunology.
615  0$aImmune response.
615  0$aPathogenic microorganisms.
615  0$aBioinformatics.
615  0$aDiseases$xCauses and theories of causation.
615  0$aGenomics.
615 14$aImmunology.
615 24$aAntimicrobial Responses.
615 24$aComputational and Systems Biology.
615 24$aPathogenesis.
615 24$aGenomics.
676   $a571.96
676   $a616.079
700   $aSoni$b Vijay$01768452
701   $aAkhade$b Ajay Suresh$01768453
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910886987103321
996   $aAntimicrobial Resistance: Factors to Findings$94229442
997   $aUNINA